1st test endocrine Flashcards

1
Q

Wolfram Syndrome

A
rare
progressive
degenerative 
transmited AR
DNA
central diabtes insipidus
DM
optic atrophy - blindness
neurosensorila deafness
neuro/psch alterations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neurohipofisis

A

post pituitary
connected to hypothalamus via axons
secretes vasopressin and oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nephrogenic Diabetes Insipidis

A

ADH is okay but its afunctional

rec is messed up

poor response of renal tube cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

classification in NDI

A
primary
familiar congenital (AD X linked)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

secondary NDI

A

tubulointersticial nephroamties
polycystic kidney, distal tubular acidosis, cistinosis, idiopathic hypercalciuria, renal amyloidosis
secondary tubularintersiticail nefropathy

litio
demeclocicline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DIC

A

altered conservation of body water as a consequence of inadequate ADH
large V of water eliminated in urine

poliruia
compensatory [plidipsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

psycogenic polydipsia or primary polidipsi

A

increased ingestion of water more than necessary –> physiological suppression of ADH due to over hydration and hypotony –> polyuria (sudden 10-12L), nicturia, polydipsia

hipoosmotic polyuria

hypovolemia and hypotension

hypertonic dehydration

astenia with sleep disorder

hipernatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PP seen in

A

young women
psychiatric px
fenotiazide (dry mouth) takers
hypothalamic lesions alteraing thirst center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal urine

A

50cc/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cause of primary DIC

A

immunolocial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

secondary cause of DIC

A
tumor
qx
trauma
IC tumor = 3rd cause
craneofaringeoma in kids
lung breast CA metastasis in adults
supraselar germinomas
intraselar GI tumors via metastasis
toxoplasmosis, herpes simplex, AIDS, 
qx
truma
Lawrence Moon Biedel Synrome

linfocitic hipofifis (infiltariotn)??

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

phases of DIC from head trauma

A

polyuria 4-5 days
secondary to transsphenoidal qx

2-3d after qx -> polyuria
this alters ADH liberation

oliguria 4-5d
(cell degeneration with liberation of preformed hormone into circulation)

polyuria and polydipsia (compensatory)
neurosecretory cell death causes Permanent ADH deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cx of Lawrence Moon Biedel syndrome

A

obesity, mental deficit, pigmental rhinitis…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

dx DI

A

<1010 urine density
urine and serum electrolytes (one high one low)

hypernatremia

plasma osmolarity > 350 mOsm/L

urine osmolarity (lower)

prueba de depuracion aquosa - remove all diuretics, solutions, ingestion - (doesn’t have - oliguria - anuria) if they do will have polydipsia from IC liquid –> coma (2-4hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is endocrinology

A
  • Branch of internal medicine that studies regulatory functions of hormones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anatomy of hypothalamus

A
  • Weight = 4gr

- 0.3-04cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

tx DI

A

desmopresin - agonist of ADH uniting with V2 rec of acuoporin –> tubular water reabsorption
VO/SC/Spray
1-2mg every 6hr, px responds within days
something about falcemics?

hydration

clorpropamid - increases ADH action - psychiatric use

carbamacepine - increases ADH liberation (high doses) > 1200mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

irrigation of hypothalamus?

A

?

- Primary capillary plexus Hypophysary arteries ant branches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

limits of hypothalamus

A
  • optic chiasm (ant)
    • thalamus/3rd ventricle (sup)
    • mamillary bodies (post),
    • infundibulo tallo-hipofisario (int)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ADH is also produced where

A

adenohipofisis

periventricular nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SSIADH

A

excessive persistend ADH secretion , not responding to inhibition -

retain water
low plasma osmolarity - dilution, high urine osmolality

edematized
oliguria

water retained

hyponatremia
nypoosmolarity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

2 connections of hypothalamus hypofisis

A
  1. Sistema porta hipotalámico-hipofisario.
    • Originates in eminencia media.
    • retrógrado & anterógrado flow
    • parvocelulare hypothalamic neurons (parvo = small [short axón -magnocelulares]) secrete hormones that reach AP
  2. Neuronas hipotalámicas magnocelulares send axons to NP.
     ○ Porta-hipotalamo-hipofisario = anterior (circulatory)
         • Eminencia media is where portal system is formed
     ○ Neuronas neurohipofisarias magnocelularesPosterior from hypothalamic neuronal axonal connection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MC of SSIADH

A

change personality irritable confusion hallucinate nausea vomit, extrapyrimadial signs
convulsion crisis, altered consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

DX criteria of SIADH

A

TABLE… fundamental

complentary
uricemia < 4mg/dL
BUN < 10mg/dL
FENa > 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
functions of hypothalamus can be
endocrine or non endocrine
26
tx of SIADH
``` hydration - hypertonic saline ADH blockers (carbonate litium) loop diuretic ``` vaptan (conivaptan, tolvaptan, relcovaptan)
27
endocrine function of hypothalamus
``` 1. parvocelular neurons secrete liberating facors or inhibitory that act at AP. Magnocelular neurons (supraóptico & paraventricular nuclei) send axons to NP, store these products ```
28
ADH does what
retains water reabsorbs Na+ secretes K+
29
no endocrine function of hypothalmsu
Based in nuclei that regulate sleep, thirst, T, appetite, libido, weight.
30
hyperprolactinemia
incrased prolactin plasma levels > 20ng/mL in men too much produced or liberated and systemic effects >25ng/mL in wommen 2 separate occations amenorrea,/oligomenorrea galactrea produced in lactotrope cells
31
What is hypothalamus?
- The hypothalamus controls the anterior and posterior pituitary's release of hormones differently.  
32
substances that stimulate prolactine/etiology of hiperprolactinemia
``` TRH striadol GnRH AVP oxytocin Serotonin AcH glutamate ``` ``` physiological : stimulation of pezon sex sleep ovulation pregnancy neonatal life ovulation lactancy ingesting AAs exercise emotional stress and physical Trauma qx Hipoglucemia IAM Convulsiones del lóbulo temporal Síncope Venopunción Deshidratación Dolor ``` DRUGS
33
sub that inhibit prolactin
``` dopamine opoid GABA GAP somatostanina, ......... ```
34
first cuase of non tumoral hipoerprolactinemia from drugs EXAM
cause 25-100ng/dl metoclopramida, risperidona, fenotiazina à >200ng/mL) if MC change tx - stop for 3 days , reread levels to see if secondary to drug Si la medicación no puede ser descontinuada y el inicio de la hiperprolactinemia no coincide con el inicio de la terapia, se recomienda MRI de hipófisis en busca de prolactinoma.
35
increased prolactin due to hypothalamic damage
``` tumors granulomatouse and infiltrative diseases cranial RT vascular cause seccion of tallo ``` also alterations of hypofisis
36
hyperprolactinemia from hypothyroidism
due to increased TRH --> secrete effect on lactotrope cells (more sensibile) decrease sensibility of lactrotoope cells to dopamine increased VIP decrease in PRL wasting in circulation o aclaramiento renal (hipometabolic state lowers GFR) - more in plasma hypofisiary hyperplasia (like puberty )
37
most cells in pituitary are...?
????
38
polyscystic ovary syndrome - PRL
hyperandrogen and estrogen --> lots of estradiol which stimulates prolactin liberation increase number and size of lactotropes decrease of dopamine hypothalamus increased transcriptionfor PRL resistence to dopamine acction
39
adrenal deisease PRL
increased transcription increased lactotrophe cell differentiation PRL increased secretion
40
liver disease PRL
cirrhosis decreased hepatic circulation of PRL increases steroidogenesis - more estrogen/estradiol decreased hypothalamic dopamine (dad)
41
Renal disease PRL
rests action nof dopamine | resists.....PRL
42
isiopathic hyperprolactimea
microprolactinomas? 20% of cases MRI cortes ateration /inactivation of dopamine rec
43
lesions of thorax wall PRL
``` toractomy masectom trauma mammoplasty dermatitis burns herpes zoster breast cyst nipple piercing ``` any stimulation of 4,5,6 intercostal nerve increases neuronal afferent stimulation postsynaptic increased serotonin liberation with stimulates TRH --> PRL increase
44
ectopic production of PRL
``` hypernefroma renal adenoCA bronchogenic CA uterine fibroma ovaric teratioma gonadotroma ovaric dermoid cyst Hodgkin linfoma and T cell linfoma ``` macroprolactinoma and med form before??
45
MC of hiper PRL
increases hypothalamus of dopamine and beta-endorphins rec of PRL in GnRH cells down regulation of GnRH (hypogonadism, galactorrea, hirsutism) decreasd ovarian secretion of estradiol and progesterone (no LH, FSH for steroidogenesis at ovary_ decreased testosterone decreased 5alfa-reductase (converts dihydro..to testosterone) 1. Galactorrea: 80% hiperprolactinémicas, 30% hiperprolactinémicos. 2. Hipogonadismo hipogonadotrópico. Hay ↓FSH, ↓LH, debido a que: a. Neuronas de GnRH tienen receptores para PRLà ↓liberación de GnRH. b. ↑PRL à ↑DA + ↑β-endorfinas en hipotálamo à ↓liberación de GnRH. ``` women Hipoestrogenismo à ¾ Amenorrea / oligomenorrea. ¾ ↓libido. ¾ ↓lubricación vaginal à Dispareunia ¾ Osteopenia/osteoporosis: ↓densidad ósea (-25% lumbar), irreversible ¾ Irritabilidad ¾ Oleadas de calor. Infertilidad. ``` ``` men Hipoandrogenismo: PRL à ↓actividad 5α-reductasa à ↓dihidrotestosterona. ¾ Disfunción eréctil. ¾ ↓libido. ¾ Oligospermia à infertilidad. ¾ ↓volumen eyaculado. ¾ Ginecomastia. ¾ Osteopenia/osteoporosis. ``` la mujer. ¾ PRL à ↑producción ovárica de andrógenos y adrenal de DHEA-S (sulfato de dehidroepiandrosterona). ¾ PRL à ↓síntesis hepática de SHBG à ↑proporción de esteroides sexuales libres (biológicamente activos) en plasma.   Presentación clínica 2. Prolactinemia >200ng/mL. 3. Clínica: galactorrea, hipogonadismo hipogonadotrópico, hirsutismo, efecto de masa (neuroftálmicos, hipopituitarismo).
46
sampling in hiperPRL
2 separate occasions 1-2 hour after waking up discart other causes (meds, liver, preg, renal failure, mammillary stimulation, sex) macroprolactinemia in asymptomatic px (no galactorrea but elevated levels - sim hormones?) drugs 1:100 dilution
47
dx evaluation of hiperprolactimea
hipofisary macroadeoma measure PRL below 200 1:100 dilution - discart hook effect if above ya tu sabe if below 200 - pseudoprolactinoma (something else compressing, dopamine e obstructed) more than 200 - macroprolatinoma1) Tomar muestra adecuadamente: ¾ 2 muestras separadas por 20-40 minutos >1h después de haber despertado, sin tener sexo (coito, manipulación de mamas) o ejercicio. ¾ Diluir muestra 1:100 para evitar efecto hook. ¾ Excluir mediante historia clínica y examen físico: embarazo, uso de fármacos; mediante laboratorio: hipertiroidismo (T4 libre, TSH), IR (creatininemia), IH (transaminasas y fosfatasa alcalina). Si nada de lo anterior es evidente o prolactinemia >100ng/mL: 2) MRI de hipófisis antes y después de administrar gadolinio. ¾ Si se confirma adenoma hipofisario à û Evaluar función hipofisaria û Campimetría visual computarizada (en particular si es un macroadenoma). ¾ Si no se confirma adenoma hipofisario à hiperprolactinemia idiopática.  
48
tx of hiperprolactinmeia
dopamine agonsits Tx de elección. Se unen a D2 en superficie de lactotropas normales y tumorales y producen inhibición de PRL, como lo haría la DA, restauran función gonadal y causan regresión tumoral en 80-90%. Se deben usar de por vida. a) Bromocriptina. Aprobada por FDA. b) Cabergolina. Aprobada por FDA. La más potente y se da 1-2x/semana. c) Quinagolida. d) Lisurida. e) Pergolida. qx - if px wont take drugs, 1. Tumorectomía transesfenoidal, indicada en: ¾ Intolerancia/resistencia a los agonistas de DA. ¾ No deseo de consumir agonistas DA por largo tiempo. ¾ Crecimiento de prolactinoma a pesar del uso de estos. ¾ Deseo de embarazo por parte de la paciente (aunque la mayoría no crece durante el embarazo: indicación relativa). ¾ Prolactinomas con componente quístico. ¾ Preferencia del paciente. ¾ No mejoría de los campos visuales tras 1-3 meses de agonistas DA 1. Agonistas de DA. Tx de elección. Se unen a D2 en superficie de lactotropas normales y tumorales y producen inhibición de PRL, como lo haría la DA, restauran función gonadal y causan regresión tumoral en 80-90%. Se deben usar de por vida. a) Bromocriptina. Aprobada por FDA. b) Cabergolina. Aprobada por FDA. La más potente y se da 1-2x/semana. c) Quinagolida. d) Lisurida. e) Pergolida. Tumorectomía transesfenoidal, 2. Radioterapia hipofisaria. Fallo en tx médico y quirúrgico. 150-200 rads/día, 5x/semana por 5 semanas. Dosis total: 4,500-5,000rads. Alta probabilidad de desarrollar hipopituitarismo.  
49
tx if drugs and qx don't work for hiperPRL
2. Radioterapia hipofisaria. Fallo en tx médico y quirúrgico. 150-200 rads/día, 5x/semana por 5 semanas. Dosis total: 4,500-5,000rads. Alta probabilidad de desarrollar hipopituitarismo.
50
2 types of hypothalamic cells
hypofisiotropic hypothalamic (liberators and inhibitors) vs neurohipofisiary hypothalamic (oxytosin and AVP/ADH)
51
liberators do what?
induce hormonal secretion
52
hypothalamic liberating hormones
TRH --> TSH and prolactin CRH --> ACTH/corticotropin secretion @ suprarenal gland and proopiomelanocortin peptides (MSH, beta-endorphin) GnRH --> LH and FSH (gonadotropins) @ genitals and Prolactin GHRH/somatocrinin --> GH/somatotropin in pulses @ all organs
53
GH secretion is increased by
exercise starvation (hypoglycemia) Sleep
54
relationship between dopamine prolactin and TRH
Prolactin is under tonal dopamine inhibition, and excess TRH levels suppress dopamine.  Thus, prolactin levels will increase as dopamine decreases.  
55
hypothalamic nucleus/region for TRH
paraventricular (medial portion)
56
hypothalamic nucleus/region for CRH
paraventricular (anterior portion)
57
hypothalamic nucleus/region for GnRH
arcuate-preoptic (ant)
58
hypothalamic nucleus/region for GHRH
arcuate
59
Hypopfisis cell populations that produce for TSH
tirotrope cells
60
Hypopfisis cell populations that produce | Prolactin
lactotrope cells
61
Hypopfisis cell populations that produce | ACTH
corticotrope cells
62
Hypopfisis cell populations that produce | FSH and LH
gonadotrope cells
63
Hypopfisis cell populations that produce | GH
somatotrope cells
64
melanocyte inhibiting factor inhibits
release of MSH
65
which are the hypothalamic inhibiting hormones
dopamine (DA) - prolactin release inhibiting hormone - inhibits liberation of Prolactin and lactropes and TSH somatostatin (SS) - inhibits liberation of PRL, TSH, GH
66
region/hypothalamic nucleus for dopamine
arcuate
67
region/hypothalamic nucleus for somatostatine
supraquiasmatic periventricular region (ant)
68
lactancy hormone that stimulates milk ejection
oxytocin
69
what do AVP/ADH do
stimulate reabsorption of water
70
non endocrine functions of the hypothalamus
○ Thirst, temperature, sexual desire, etc thorugh hypothalamic nuclei
71
anterior pituitary hormones are produced by what
parvocellular hypothalamic neurons
72
anterior pituitary hormones
``` ACTH LH, FSH GH TSH Prolactin MSH ```
73
weight of pituitary gland
0.5-0.9gr
74
blood flow of pituitary gland
very vascularized | 0.8ml/gr/min
75
Situations in which Pituitary can double size:
- Pregnancy - Puberty (especially girls) - Primary hypothyroidism - Primary hypogonadism
76
% gland of adeno vs neurohipofisis
75% adeno 25% neuro
77
embryological origin of adenohipofifis
Bolsa de Rathke (evaginación del techo de la orofaringe primitiva).
78
embryological origin of neurohipofisis
Evaginación del hipotálamo ventral y del piso del 3° ventrículo
79
irrigation of adenohipofisis
Arteria hipofisaria superior + sistema porta hipotalámico (0.8ml de sangre/g de tejido)
80
irrigation of neurohipofisis
Arteria hipofisaria media + Arteria hipofisaria inferior
81
Venous drainage of pituitary glland
cavernous senos --> sup and inf petrous senos --> yugular veins --> SVC --> RA
82
pituitary cell types
* Nulas - don’t secrete hormones, do secrete NTs | * Secretory - classified in 5 types
83
cx of somatotropic cells
@ lateral portions acidofiles 50%
84
function of somatotropic cells in skeletal muscle
increases muscle mass increases AA capitation decreases proteolysis decreases glucose capitation (CONTRAREGULATOR) --> hyperglucemiant
85
function of somatotropic cells in adipose tissue
``` decrease capitation of glucose increase lipolysis (degradation of TGs/FAs) -increases activity of hormonosensible/GH lipase ```
86
function of somatotrpic cells in liver
increase protein synthesis increases gluconeogenesis (formation of glucose from lactate, pyruvate, glycerol, AAs) increases IGF-1 synthesis (somatomedine C) --> which in turn increases bone lineal growth , muscle and visveral growth
87
what is IGF-1
a cofactor that helps GH functions/efficacy = NECESSARY
88
cx of lactotrpic cells
acidofiles posterior 10-25%
89
function of lactotropic cells
in mammary glands increase milk production during lactancy decreases GnRH (FSH LH) --> amenorrea
90
cx of corticotropic cells
basophils | 15-20%
91
function of corticotropic cells
@ adrenal cortex increase growth, development, vascularization increase LPL capitation which increases synthesis and adrenal secretion of glucocorticoids (cortisol) and sex steroids (androgens and estrogens) increases melanin synthesis stimulate mineralocorticoids, sex hormones increase CyP450 : cholesterol --> pregnenolone decrease GnRH and GH
92
cx of gonadotropic cells
basophiles anterior 10-15%
93
function of LH in women
theca cells: make androgens - testosterone and androstenedione by theca cells in ovaries that by diffusion pass to granulouse cells (through aromatase converts androgens to estrogens) ovaric follicle: rupture causing ovulation
94
function of LH in men
Leydig intersticial cells of testicle: synthesis and secretion of testosterone decreases hypothalamic secretion of GnRH and pituitary secretion of FSH and LH by RAN
95
function of FSH in w0men
acitmates aromatase androstenedione --> estrone (E1)in adipocytes testosterone --> estradiol (E2) growth and follicular development dominant foliculo selection production of inhibine by granous cells in ovaries which cause less secretion of FSH from pituitary
96
estrogen byexcellence
estradiol
97
function of FSH in men
proliferation of seminiferous tubes principal determinant of testicular volume spermatogenesis production of inibine thru sertoli cells in the testicle --> decreases pituitary FSH secretion
98
cx of tirotropic cells
anterolateral anteromedial 10%
99
function of tirotropic cells in thyroid
stimulate vascularity and thyroid growth stimulate production of T3 and T4 morphological changes causing pseudopod formation increases iodine trapping and bone reabsorption (that's why hyperthyroidism causes early osteoporosis) decreases colloid, fotitias of IC colloid stimulates tiroglobulin hydrolysis 6. Iodine metaoblism phases stimulation 7. Increases mRNA of tiroglobulin and thyroid peroxidase 8. Increases 5' deyodase I (T4-->3 peripheral) 9. Glucose captation, O2 consumption and CO2 production +
100
hormones that share alfa subunits
LH FSH TSH
101
80% of somatomelina C / IGF-1 produced where?
liver but it acts in the muscle =
102
how can IGF-1 lead to microsomal children
mothers pancrease stimulates insulin also stimulating IGF-1
103
which homones are glucoproteins
TSH LH FSH share homology
104
which are somatotropins
PRL | GH
105
irrigation of hypothalamus
thru superior hypophyseal artery
106
TFs involved in development of adenohipofisary cells
5. POU1F1 (Pit-1): lactotropas, somatotropas y tirotropas. 6. Prop-1: gonadotropas. (promiscuous) 7. T-pit: corticótropas.
107
TSH also stimulates
estrogen
108
ADH nucleus
is a nonapeptide that is synthesized predominately in the supraoptic nucleus of the hypothalamus, and secreted from the posterior pituitary upon stimulation of these cell bodies. 
109
primary stimulus for ADH secretion
``` The primary stimulus for antidiuretic hormone (ADH) secretion is an increase in serum osmolarity.  A loss of intracellular water from hypothalamic osmoreceptor neurons bathed by hyperosmolar blood will stimulate ADH release.  Other factors that increase ADH secretion include: • Pain/stress • Hypoglycemia • Nausea • Volume contraction • Nicotine and opiates • Angiotensin II ```
110
2 primary functions of ADH
* Regulate serum osmolarity * Maintain (increase) blood pressure Antidiuretic hormone also increases the permeability of the inner medullary collecting duct to urea.  This increases the osmotic gradient created by the countercurrent multiplier, facilitating the production of concentrated urine (i.e. increasing urine osmolarity). - Increases water reabsorption in renal colector tubules - Modualtes BP by increasing SM arterial tone Stimulates liberation of ACTH by hypofisary corticotrope cells
111
oxytocin nucleus
Oxytocin is a nonapeptide that is primarily produced by the paraventricular nuclei within the hypothalamus, and secreted from the posterior pituitary
112
how does oxytocin travel to posterior pituitary
Like ADH, oxytocin travels to the posterior pituitary via carrier proteins called neurophysins. 
113
stimulus for oxtocin secretion
The major stimulus for oxytocin secretion is suckling.  Other positive stimuli include dilation of the cervix and orgasm, Bconfidence , memory, conection and empathy.
114
effects of oxytocin
The primary effects of oxytocin are milk ejection @ lactation and uterine contraction @ labor.
115
adverse effects of oxytocin
* Hyponatremia and seizures (due to anti-diuretic properties similar to antidiuretic hormone) * Subarachnoid hemorrhage * Uterine rupture in pregnant patients
116
irrigation of hypothalamus
MCA of ICA
117
function of thyroid hromones
``` Thyroid hormones: • induce central nervous system maturation during growth • increase basal metabolic rate • increase cardiac output • promote bone growth ```
118
what stimulates TRH
cold
119
what inhibits TRH
stress
120
what inhibits TSH
DA, SS, cortisol, GH, T3 y T4 thyroxine
121
TSH does what
stimulates T3 and T4 secretion from thyroid and - neg feedback to decrease TRH and TSH @ thyroid increase growth and vascularity, capitation of I- inorganic, increases oxidation of Inorganic I- creating more reactive yodant species (EIRs) 4) ↑Incorporación de EIR en residuos tirosina de la tiroglobulina[4] à ↑formación de yodotirosinas: MIT[5] y DIT[6]. increases formation of thyroid peroxidase 6) ↑Acoplamiento de yodotirosinas: MIT + DIT = T3, DIT + DIT =T4. 7) ↑formación de la gota de coloide. 8) ↑Liberación de T3 y T4.
122
what increases TSH
TRH and estradiol
123
difference between types of hypothyroidism
a. Primary: damage to thyroid gland: ↑TSH + ↓T3 y T4. b. Central: ↓TSH (o inapropiadamente normal) + ↓T3 y T4. Secundary: damage/disfunción of tirotrpic cells that makeTSH. Terciario: damage /disfunción to hypothalamic neuronas that produce TRH. 2° y 3° son bioquímicamente indistinguibles. ``` - Pirmary = @ thyroid gland ○ High tsh ○ Low T4 - Secondary ○ Both low - Tertiary ○ Both low ```
124
90% of T3 in circulation comes from
T3 circulante (forma biológicamente activa) se deriva de la T4.
125
feedback of increased cortisol
less hypothalamic secretion of CRH and hypofisary secretion of ACTH (por RAN)
126
what increases ACTH
CRH and AVP Stress, trauma , int. qx, infections, hypoglicemia (similar to GH contraregulatory hormones)--> ACTH and catecolamines @ adrenal gland
127
cortisols effect on hormones
AVP, ↓CRH, ↓ACTH, ↓GnRH.
128
what is cortols made from
cholesterol and needs cytochrome p450
129
cx of cortisol
- Catabolic - hyperglucemic - Anabolic only I liver --> + cytocrome p450 - Antiinflammatory - Immunosuppressor
130
different types of hypoadrenalism
c. Primary (Addisons disease): damage to adrenals ↑ACTH + ↓cortisol + hiperpigmentación of skin and mucus due to RAN deficit). d. Central: ↓ACTH (o inapropiadamente normal) + ↓cortisol. Secundary: damage/disfunción in corticotropas cells that produce ACTH Terciary: damage/disfunción hipotalámic neurons that produce CRH. Primary Adrenal Insuff - ACTH up - Low cortisol Secondary @ corticotrope cell lesion - Both down Hypofisis trurmor of ACTH - Both up Adrenal tumor that secretes cortisol - Low ACTH - High cortisol
131
circadian rhythm of cortisol secretion
- Different quantitites @ different times - máxima @6:00-8:00am; - mínima @12:00am.
132
how to know if there is a loss of cortisol circadian rythm
- Para determinar si hay pérdida de este ritmo circadiano (propio del Síndrome de Cushing Endógeno) se mide cortisolemia @8:00am (5-25μg/dL) y @4:00pm (suele estar al 50% respecto a 8:00am, es decir, 2.5-12.5μg/dL)
133
GnRH pulse
Hipotálamo produce GnRH en pulsos de 60/90-120 minutosà sistema porta va a gonadotropas adenohipofisarias à ↑FSH (end) y ↑LH. (beginning)
134
different types of masculine hypogonadism
primary (hypergonadotropic) damage , testicular dysfunction - ↑FSH + ↑LH + ↓testosterona + ↓inhibina. Central (hypogonadotropic) - ↓FSH + ↓LH + ↓testosterona + ↓inhibina ...secondary - damge corticotropes that produce FSH and LH ...tertiary - damage to hypothalamic neurons that produce GnRH
135
aromatase
- Testosterone to estradiol (E2) -↓hipotalámic secretion of GnRH and pituitary FSH y LH (por RAN), when secreción is >200pg/mL during >40-50h will be ↑secreción hipotalámica of GnRH (por retroalimentación positiva [RAP]) à↑↑↑LH (pico de LH) à ovulación. ○ Estradiol negative feedback vs LH, FSH, GnRH - Androstenediona à estrona (E1). ¾ Also pulsatilie - If > 200mg/dl > 40-50hr --> negative feedback - more than this time --> postiive feedback --> dominant follicular rupture --> primary oocyte = OVULATION ¾ Andrógenos à ↓secreción hipotalámica de GnRH e hipofisaria de FSH y LH (por RAN). ¾ Inhibina? - Can only inhibit FSH - not LH
136
feminine hypogonadism
1. Primary (hipergonadotrópic): damage disfunción of ovary: ↑FSH + ↑LH + ↓estradiol + ↓inhibina. 2. Central (hipogonadotrópico): ↓FSH + ↓LH + ↓testosterona + ↓inhibina Secundario: damage/disfunción en corticotropas productoras de FSH y LH. ¾ Terciario: damage/disfunción de hipotalámic neurons that produce GnRH.
137
where is the Kiss1 gene
``` in hypothalamus (núcleos anteroventral periventricular [AVPV] y arcuato), placenta and oncocytes --> produces 145 AA protein that is cleabed into 4 peptides: (Kisspeptines - ligands of Kiss1-R (GPR54 linked to G protein expressed in productor neurons of GnRH) ○ Discovered in philadelphia - hersheys kisses ``` - Kp54 (metastine), Kp14, Kp13, Kp10
138
function of kisspeptins
Sex steroids increase Kiss1 gene expresion in AVPV nucleus and degrease it inn arcuate nucleus --> LH peak Stimulate GnRH liveration Initiate puberty ¾ Regulation of ovulation (neuroendocrine) ¾ Initiation, maintenance, and regulation of fertility
139
3 circulation forms of prolactin
3. native PRL (de 23.5 kDa). the one that is normally secreted in 6-14 pulsos during the day(60% while sleeping). 4. Big-PRL (de 50kDa).co secreted in small quantities 5. Big-Big-PRL (de 150kDa). also cosecreted in small quantities
140
macroprolactina
all 3 PRL + 1 IgG immunoreactive low biological activity
141
dx macroprlactinemia
measure prolactin precipitación inpolietilenglicol o cromatografía . gel
142
when to suspect macroprolactinemia
Suspect macroprlactinemia? - fem, high prolactin, no drugs that stimualte , no galactorrea - at expense of macroprolactins, also inhibit GnrH in asymptomatic px with hyperprolactinemia
143
inhibitors of PRL secretion
``` Dopamina[1][2] Somatostatina GABA (ácido γ-aminobutírico). GAP (péptido asociado a GnRH) Calcitonina. ```
144
stimulators of PRL secretion
``` Estradiol[3] TRH GnRH AVP Oxitocina VIP Serotonina Bombesina ``` ``` Galanina Histamina Neuropéptido Y Sustancia P Angiotensina II Neurotensina Péptido histidina-metionina ```
145
Physiological factors that liberate PRL (date night)
``` stimulación de las mamas Coito, especialmente en mujeres Sueño Ovulación Embarazo Vida neonatal Lactancia Ingesta de aminoácidos Ejercicio ```
146
ACTH does what @ adrenals
increases growth and development of adrenal cortex increases adrenal capture of lipoproteins (cholesterol is substrate for adrenal steroidogenesis) increases activity for CyP450scc, enzyme that transforms (cutting lateral chain) cholesterol --> pregnenolone increases stimulation of MSH alfa-R --> which increases synthesis of melanin by melanocytes
147
action of kisspeptines in hypothalamus
increases secretion of GnRH to begin puberty neuronendocrine control of ovulation initiation, maintenance, metabolic regulation of fertility
148
Prolactin function
stimulates production of maternal milk during latency
149
differentiating types of hyperthyroidism
``` Hyperthyroidism - Primary ○ Low TSH ○ High T4 - With levated TSH and T4 ```
150
Hipergonadotropic Hipogonadism
- High LH and FSH | - Low estradiol , low testosterone
151
Hipogonadotropic Hipogonadism
- Both low
152
cx of hypofisary adenoma
- Benign tumors of hypofisial gland - 10-15% of IC neuplasias - 3rd cause + Fc - 90% of hypofisial neoplasias
153
% of hipofisary adenomas that are prolactinoma
45% □ Inhibit GnRH can call a combined syndrome
154
epi cx of prolactinoma
○90% Micro in women, 60% macro in men ○ 3rd decade women ○ Men older (Son 8 veces más frecuentes en mujeres y se suelen diagnosticar entre 20-40 años.
155
MC of prolactinoma in men
disfunción eréctil, disminución volumen testicular y del eyaculado, oligospermia, ginecomastia., glactorrea, low libido, infertility, azoospermia
156
what is prolactinoma
○ Tumor of lactotrope cell line mostly in adenohipofifsis ' ○ Cosecretion of hormones and PRL level hyperprolactinemia --> decreased secretion GnRH --> decreased LH and FSH
157
pseudoprolactinoma
effecto de tallo - too much prolactin from compression of tallo macroadenomas even if they aren't prolactinomas cause hyperprolactinemia < 200ng/mL due to effecto de tallo
158
MC of prolactinoma in women
amenorrea, oligomenorrea, disminución lubricación vaginal, dispareunia, oleadas de calor, osteopenia/osteoporosis. Falla en menarquia, regular period with short lutea fase, infertility, low libidio, galactorrea i. Inhhibition of GnRH
159
MC of prolactinoma common to both sexses
decresed libido, infertlility e. Reduction of bone mass and osteoporosis
160
mass effect MC of prolactinoma
i. Loss of vision ii. Headache iii. Convulsions iv. Hydrocefaly v. Unilateral exoftalmo vi. Paralysis of craneal nerves ○ Neurological/oftalmological ○ Headache, IC HTN, convulsions, apoplejia, compression of quiasm
161
Hook Effect - de cancho
results in elevated PRL levels which interfere with immunoradiometric ensayo and arrojan a abnormally low cifra (20-200ng/ml) what would lead one to believe its a nonsecreting macroadenoma to aboid this sample should be diluted 1:100 if there is a pituitary macroadenoma and prolactinemia < 200 if its still in 20-200 range its a pseudo prolactinoma i. >200ng/dl ii. Interference with radioimmunoensayo iii. Low PRL
162
before samplimg for prolactinoma what is important to consider
i. Take prolacin 1-2hr at wake up to aboid false + ii. 2 separate elvated tests iii. Discard hyperprolactinemia (pregnancy meds 25-100ng/ml, hypothyroidism, renal insuff, or hepatic insuff)
163
hipofisial adenoma 20%
somatotropoma ○ High GH ○ Gigantism , acromegaly
164
hipofisial adenoma 10-12%
corticotropoma ○ High ACTH ○ Cushingnhibit GnRH ® So these we cause combined sydrome
165
hipofisial adenoma 1-2%
tirotropoma ○ High TSH | ○ Bocio and hyperthyroidism
166
hipofisial adenoma 15%
gonadotropoma ○ High FSH, LH ○ No clinical syndrome
167
hipofisial adenoma 5-10%
tumor of celulas nulas
168
what is hypopituitarism
○ Low hormonal secretion (2 or more) ○ Can be total Syndrome --> decrease/absence of 1 or more hormones of pit. Gland
169
mechanisms for hypopituitarism
``` § Tumor compresses hypothalamus - decreasing § Compressing pit. Gland § Compression of THH § Decrease of pit. Irrigation § Necrosis of hipofisis ```
170
what is combined syndrome
- Combined syndrome of hypersecretion of 1 hormone associated to decrease in secretion of 1 o more adenohipofisial hormones
171
microadenoma
< 10mm
172
what is corticotropoma
hypersecretion of ACTH --> hyperproduction of adrenal cortisol --> decreased GnRH --> decreased LH, FSH, GH
173
examples of microadenomas
prolactinoma | corticotropoma
174
macroadenoma
> 10mm ○ More in adults ○ Mechanical compression of hypothalamus, hypofisis, infundibulo, portal vessels --> focal pituitary necrosis ○ (craniofaringioma in kids)  
175
neurological MC of hypopituitarism??
1. Cefalea. 4. Epilepsia del lóbulo temporal. 7. Alteración de conciencia (somnolencia, estupor y coma). 2. Parálisis de NC III, IV, VI (compresión senos cavernosos). 5. Rinorrea de LCR (si destruye piso de silla turca). 8. Defectos de campos visuales (hemianopsia bitemporal; por compresión del quiasma óptico). 3. Hidrocefalia obstructiva (compresión 3° ventrículo). 6. Obstrucción vía aérea nasal. 9. Disminución agudeza visual y ceguera (compresión del nervio óptico y de las cintillas).
176
hipofisial apoplejia
Spontaneous Infarto/hemorrage of hypophysary adenoma (10-15%) clinically in 66%.
177
local consequences of hipofisial apoplejia
Signos de irritación meníngea: cefalea, Kernig, Brudzinski. Parálisis ocular, diplopía, proptosis, defectos de campos visuales. Alteración de la conciencia Alteración de autorregulación simpática Dolor facial Hidrocefalia obstructiva
178
systemic consequences of hipofisial apoplejia
``` Hipopituitarismo: 1. Insuficiencia suprarrenal secundaria aguda: hipotensión y choque. 2. Hipotiroidismo central. 3. Hipogonadismo secundario.   Silla turca vacía ```
179
wermer syndrome
(Múltiple Endocrine Neoplasia 1, las 3 P). HAD, coexistence of 2/3of the following: 1. Pituitary adenoma. a. In 60% of NEM1, generally prolactinomas (60%), somatotropomas y corticotropomas, y generally are macroadenomas. 2. Primary Hiperparatiroidism (from hiperplasia or multiple adenomas). a. Initial clínica-bioquímica presentation. b. 60-90% of NEM1. 3. pancreáticos y duodenales neuroendocrinos tumors: insulinomas, glucagonomas, gastrinomas, VIPomas, somatostatinomas.  
180
gigantism vs acromegaly
excessive secretion of GH that if before closure of hipofisis is gigantism (prominent lineal growth of long bones) if after closure = acromegaly (exaggerated growth of bland tissues, bones of hands, feet, mandible, internal viscera)
181
etiology of gig/acro
somatotropoma 1. Somatotropoma productor de GH (99%). 65% son macrosomatotropomas. 2. Secreción ectópica de GH: in pancreatic and lung cancer ``` 3. excessive secretion of GHRH Eutópica: gangliocitoma o hypothalamic coristoma . b. Ectópica: Tumores islotes pancreáticos. ¾ Carcinoides bronquial, intestinal o tímico. ¾ CA microcítico de pulmón. ¾ CA medular de tiroides. ¾ Feocromocitoma. ¾ Adenoma adrenal. ```
182
general MC of gig/acro
``` Fatiga Intolerancia al calor Ganancia de peso Diaforesis Hiperhidrosis palmoplantar ```
183
osteomegalia in gig/acro
Prognatismo: aumento de espacios interdentales maloclusión. Dedos engrosados y elongados (acropaquia)[1]. Rasgos faciales grotescos[2]. Crecimiento de manos y pies[3] Tórax en tonel[4]
184
Dermatolomegalia ig/acro
Engrosamiento cutáneo por depósito de glucosaminoglucanos. Hipersecreción sebácea: piel oleosa, acné, quistes sebáceos. Hipertricosis (50%). Cutis verticis gyrata[6] Hiperpigmentación (40%) Papilomas Acantosis nigricans[5] (10%) Moluscos fibrosos
185
organomegalia acro/gig
``` Laringomegalia y apnea del sueño Parotidomegalia Nefromegalia Hepatomegalia Macroorquidismo   Cardiomegalia (15%) asociada a ICC/ cardiomiopatía hipertrófica. ```
186
endocrinological metabolopathies in acro/gig
``` HTA (25%) Intolerancia a glucosa (50%) DM (25%) Hiperfosfatemia[7] Hipocalcemia por hipercalciuria[8] Nefrolitiasis Hipopituitarismo[9] Hiperprolactinemia[10] ```
187
neuropathy in acro/gig is due to
comprisive effect
188
neuroatropathies in acro/gig
Neuropatía periférica por compresión de nervios periféricos por osteomegalia. Compresión de médula espinal. Síndrome del túnel carpiano Artropatía.
189
dx of gig/acro
Medir IGF-1 (somatomedina C, (+: >1ng/mL) o GH (+: >1ng/mL) en sangre a los 0, 30, 60, 90, 120 minutos. 2) MRI de hipófisis con gadolinio à a. adenoma hipofisario: evaluación hormonal + campimetría visual computarizada b. No adenoma hipofisario: GHRH en plasma, MRI de tórax, TAC de abdomen.
190
tx of gig/acro
1) Extirpación transesfenoidal. Cura 70% de microadenomas y 50% de macroadenomas. 2) Análogos de la somatostatina: lanreótido, octreótido. Inhiben síntesis de GH hasta en un 90% por somatotropas y reducen tamaño tumoral. 3) Pegvisomant. Bloquea unión a GH-R. 4) Agonistas dopaminérgicos: bromocriptina, cabergolina, quinagolida, lisurida y pergolida a dosis mayores que las usadas para prolactinomas. 5) Radioterapia hipofisaria, con el riesgo de producir hipopituitarismo. Tx dura 6 meses a 20 años, pero normaliza los niveles en 90% de casos.  
191
Etiology of CUshing syndrome
deberse a: ¾ Exógeno. Forma más frecuente. Por el uso a dosis excesivas o prolongadas de glucocorticoides (estados inflamatorios crónicos). Endógeno. Por tumor productor de ACTH,
192
endogenous causes of Cushing are classified into
ACTH dependent (excess produced due to tumor which increases cortisol production by suprarenals) and ACTH independent (excess cortisol produced by adrenal hyperplasia/tumor) Cortisol causes RAN on ACTH
193
ej of ACTH dependent causes
§ Corticotropoma hipofisario (“Enfermedad de Cushing”). 68% de casos de síndrome de Cushing endógeno en adultos. Secreción ectópica de ACTH por tumor extrahipofisario. 12% de casos de síndrome de Cushing endógeno en adultos.
194
acute presentation of ACTH dependent causes of cushing
CA de pulmón 75%.
195
chronic presentation cushing (ACTH dependent)
v Carcinoides bronquial, intestinal o del timo. v Tumores de células de los islotes pancreáticos, especialmente insulinomas. v CA medular del tiroides. v Feocromocitoma. § Síndrome de secreción ectópica de CRH por tumor extrahipotalámico. <1% de los casos de síndrome de Cushing endógenos en adultos. v CA medular del tiroides. v Carcinoide bronquial. v CA de próstata metastásico.
196
ej of ACTH independent causes of cushing
§ Adenoma/CA productor de cortisol. | § Hiperplasia micronodular/macronodular.
197
general MC of cushing
Obesidad centrípeta Cefalea Psicopatías Miastenia proximal
198
cutaneuous MC of cushing
``` Estrías purpúricas >1cm de diámetro @ abdomen, flancos, MS, MI. Adelgazamiento cutáneo. Fragilidad capilar (equimosis o moretones espontáneos o por traumas mínimos) Hiperpigmentación (en ACTH dependiente). Cara redonda. Acné. Hirsutismo. Plétora Acantosis nigricans Micosis Pobre cicatrización ```
199
endocrinological metabolic MC of cushing
``` Alcalosis hipocalémica Retraso de crecimiento óseo Oligomenorrea/amenorrea. Alteración libido/ disfunción eréctil. HTA (80%) Intolerancia a glucosa y DM Hipercalciuria con Nefrolitiasis ``` Leucocitosis neutrofílica. Osteopenia/osteoporosis. Hiperlipidemia. Poliuria.
200
dx of cushing
confirm biochemically dx of cushing (confirm endogenous hiperorisolism) distinguish between ACTH dependent vs independent distinguish between corticotropoma vs ectopic secretion
201
how to biochemically confirm cushing
a. Cortisol libre en orina de 24h 2-4x mayor del límite superior. b. Prueba de Nugent: supresión con 1mg de dexametasona: ¾ 1° día de la prueba: 1mg VO de dexametasona a las 11pm. ¾ 2° día de la prueba: medir cortisolemia @ 8am y si es <1.8 μg/dL se excluye. c. Medir cortisol salival a las 11pm: >145 ng/dL (>4nmol/L). d. Cortisolemia >1.8 μg/dL @12nm con paciente dormido (no tiene aplicabilidad clínica). e. Prueba de dexametasona-CRH.
202
how to distinguish between ACTH dependent vs independent
Determinar ACTH en plasma: a. ACTH bajo à ACTH independiente à hacer TAC de suprarrenales. ACTH normal (10 pg/mL) /alto à ACTH dependiente
203
how to distinguish between corticotropoma and ectopic secretion
MRI de hipófisis con gadolinio à (neg) à MRI de tórax + TAC de abdomen + perfil hormonal: ¾ Insulinemia à insulinoma. ¾ Catecolaminas en suero y orina de 24h + metanefrinas à feocromocitoma. ¾ Ácido 5-OH-indol-acético en orina de 24h à tumor carcinoides. ¾ Calcitonina à CA medular de tiroides.
204
tx for cushing
1. Extirpación transesfenoidal. Cura 80%, 10-30% tiene recurrencia à 30-50% no son curados. 2. Radioterapia hipofisaria. 40% son curados (85% si son <18años). El 60% no es curado pero está protegido contra el síndrome de Nelson (crecimiento excesivo de un corticotropoma + defectos de campos visuales + hiperpigmentación cutánea [cuando tx inicial es adrenalectomía bilateral]) 3. Mitotane (adrenolítico: destructor de adrenales) + inhibidor de la síntesis adrenal de cortisol. 80% se cura. 4. Inhibidores de enzimas adrenales de la síntesis del cortisol (ketoconazol, metirapona). 5. Adrenalectomía bilateral total.  
205
10% of prolactinomas cosecrete
GH
206
cx of macroprolactinoma in men
estos producen prolactinemia >200ng/mL).
207
dx evaluation of prolactinoma
1) Tomar muestra adecuadamente: ¾ 2 muestras separadas por 20-40 minutos >1h después de haber despertado, sin tener sexo (coito, manipulación de mamas) o ejercicio. ¾ Diluir muestra 1:100 para evitar efecto hook. ¾ Excluir mediante historia clínica y examen físico: embarazo, uso de fármacos; mediante laboratorio: hipertiroidismo (T4 libre, TSH), IR (creatininemia), IH (transaminasas y fosfatasa alcalina). Si nada de lo anterior es evidente o prolactinemia >100ng/mL: 2) MRI de hipófisis antes y después de administrar gadolinio. ¾ Si se confirma adenoma hipofisario à û Evaluar función hipofisaria û Campimetría visual computarizada (en particular si es un macroadenoma). ¾ Si no se confirma adenoma hipofisario à hiperprolactinemia idiopática.
208
psychopharmacological drugs that cause hyperprolactinemia
drugs psychodrugs - decrease tono hypothalamic of dopamine Fenotiazinas (40-90%, clorpromazina y demás) Butirofenonas (haloperidol y demás, 40-90%) Risperidona (100%). Antidepresivos (IMAO, tricíclicos, IRSS) Benzodiacepinas Sulpirida Amoxapina
209
antiHTN drugs that cause hyperprolactinemia
``` Antihypertensives Metildopa y reserpina (disminuyen producción DA)   Verapamilo Clonidina Labetalol Atenolol ```
210
antiemetics that cause hyperprolactinmia
``` Antiemetics Metoclopramida Domperidona Cisaprida   Bloquean receptores D2 de DA en lactotropas ```
211
hormonal prepared drugs that cause hyperprolactinemia
``` hormonal preps Estrógenos. Disminuyen tono dopaminérgico, aumentan # y tamaño de lactotropos y aumentan síntesis de PRL. AO GABA Progesterona Serotonina (5-HT) Testosterona Noradrenalina (NE) Endorfinas TRH ```
212
toxic drugs that cause hyperprolactinemia
``` narcoticsCocaína Morfina y heroína Anfetaminas Metadona Nicotina Cerveza Codeína ```
213
antihistaminic H2 drugs that cause hyperprolactinemia
H2 histamine blockersCimetidina | Ranitidina
214
Miscellanious drugs that cause hyperprolactimeia
``` miscelanious Inhibidores de proteasas (SIDA) Fenitoína (anticonvulsivante) Isoniazida (antituberculoso) Piridostigmina (colinérgico) Medroxalol (antiadrenérgico) ```
215
causes of hyperprolactinemia that are related to damage of hypolathamus or infundible
``` Tumores: a. Craniofaringiomas. b. Germinomas. c. Meningiomas d. Metástasis a hipotálamo. e. Extensión supraselar de AH Enfermedades granulomatosas Enfermedades infiltrativas Radioterapia craneal Vasculopatías. Sección infundibular ```
216
causes of hypofisiopathy that are related to hipofiospathy
Prolactinomas (AH más frecuente). En mujeres suelen ser micro (90%, 100-200ng/mL) y en hombres macro (60%, >200ng/mL). 8x más frecuente en mujeres, edad de dx más frecuente: 20-40 años.   Macro-AH, por “efecto de tallo” (<200ng/mL). Hipofisitis linfocítica. Quiste intraselar. Quiste de hendidura de Rathke. Silla turca vacía Acromegalia (50% de somatotropomas coproducen PRL
217
causes of hyperprolactinemia associated with primary hipothyroidism
Produce híper-PRL en 10-40%. Se da por: 1. ↑TRH hipotalámica à ↑PRL 2. ↑sensibilidad a TRH de lactotropas 3. ↑VIP à ↑PRL. 4. ↓DA hipotalámica 5. ↓metabolismo PRL à ↓eliminación PRL
218
causes of hyperprolacinemia associated with polycystic ovary
Produce híper-PRL en 10-30%. Estado hiperandrogénico o hiperestrogénico (ver atrás)
219
causes of hyperprolactinemia associated with organ failure
Suprarrenal: ↓cortisol à ↑expresión gen PRL. Renal: produce híper-PRL en 20-75%. ↓depuración. Hepática: Produce híper-PRL en 5-20%. ↓depuración hepática, acumulación de estradiol.
220
causes of prolactinemia associated with thoracic wall , medular lesions
Toracotomía, mastectomía, traumatismo, mamoplastía, dermatitis, quemaduras, herpes zoster, brassiere ajustado, quiste mamario, mesotelioma, esofagitis, piercings en pezones, lesión, cirugía o tumor de médula espinal. Por estimulación nervios costales 4°-6° produce galactorrea por estimulación del SNA.
221
causes of prolactinemia associated with ectopic prodcution
``` CA broncogénico (secreción VIP) Hipernefroma AdenoCA renal. Teratoma ovárico Gonadoblastoma Leucemia mielógena aguda Linfoma de Hodgkin y de células T ```
222
causes of prolactinemia associated with - miscellanous
``` Encefalitis Neurofibromatosis Pseudotumor cerebral Seudociesis Porfiria ```
223
causes of prolactinemia associated with macroprolactienmia
Autoanticuerpos anti-“big-big” PRL. Sospechar ante hiperprolactinémicos asintomáticos, pues estas moléculas tienen muy poca actividad biológica.   Se presenta hasta en el 40% de las detecciones de híper-PRL.
224
causes of prolactinemia associated with - idiopathic
20% de los hiperprolactinémicos. Puede ser por mínimas dimensiones. Se piensa en resistencia de lactotropos a la DA o poca actividad de sus receptores. Se normalizan espontáneamente en 30%.
225
for hyperprolactinemia when is transesfenoidal tumorectomy ndicated
¾ Intolerancia/resistencia a los agonistas de DA. ¾ No deseo de consumir agonistas DA por largo tiempo. ¾ Crecimiento de prolactinoma a pesar del uso de estos. ¾ Deseo de embarazo por parte de la paciente (aunque la mayoría no crece durante el embarazo: indicación relativa). ¾ Prolactinomas con componente quístico. ¾ Preferencia del paciente. ¾ No mejoría de los campos visuales tras 1-3 meses de agonistas DA
226
what are somatotropoma
tumor of somatotropes that secrete GH
227
what is cosecreted in 20-25% in somatotropomas
PRL
228
65-80% of somatotrpomas are
macroadeomas
229
MC of somatotropomas
gigantism /acromegaly in 99% | mass effect
230
mass effect in somatotropma
(hipopituitarismo, hiperprolactinemia y neurooftalmopatías
231
< 1% of gigantism and acromegaly is due tu
ectopic secretion of GH excessive secretion of GHRH 1. Eutópica (hipotalámico): gangliocitoma o coristoma. 2. Ectópica: tiroides (CA medular), timo (carcinoide), bronquio (carcinoide), pulmón (CA microcítico), intestino (carcinoide), páncreas (CA de islotes), adrenales (adenoma o feocromocitoma).
232
Dx of somatotropoma
3. Confirmación bioquímica: a. IGF-1 (somatomedina C) elevado. b. Prueba de sobrecarga oral de glucosa midiendo GH (SOG-GH). Medir GH en ayuna y cada 30mins durante 2h después de la sobrecarga con 75g glucosa VO. Confirmación: GH > 1ng/mL por lo menos en 1 de las muestras tomadas post-administración de glucosa. 1. MRI de hipófisis con gadolinio … ¾ Positivo à a. Campimetría visual computarizada. b. Evaluación hipofisaria. ¾ Negativo à c. GHRH en plasma. d. TAC tórax y abdomen.
233
what are corticotropomas
tumors of corticotropas that secrete ACTH producing CUSHINGS disease
234
what is cushings diesase
a state of hypercortisolism due to hyperstimulation of adrenal gland
235
cortico tropoma is responsible for what percent of endogenous cushing in adults
68% 90% are microadinomas
236
biochemical confirmation of corticotropoma
a. Cortisol urinario libre de 24h. Positivo: 2-4x > límite superior. b. Prueba de supresión con 1mg nocturno de dexametasona. Se administra 1mg de dexametasona @11pm del primer día y se mide cortisolemia a la mañana siguiente. Positivo: >1.8μg/dL. c. Cortisol salival @11pm. Positivo: >145ng/dL
237
least frequent AHs 1-2%
tirotropmas
238
most invasice AHs
tirotropmas
239
% of tirotropomas that are macroadenomas
85% are macroadenomas causeing mass effect ontop of hormonal effects (bocio, hiperhyroidism with increased TSH ¾ Cosecretan GH (16%), PRL (11%), LH/FSH (1.4%) y subunidad α[2].
240
hpo vs pan
decreased or no of one or more pit hromes pan is all > 90% of mass
241
causes of hypopituitarism (one or more hormons) 8Is A
direct or indirect ``` tumoral invasion (meningioma, glioma, ) pit infarct infiltration of hipofisis infection in this region injury in this region - postqx, RT, trauma iatrogenic immunological idiopathic isolated - deficit of just one hormone ```
242
types of tumors that cause hipopituitarism
hipofisiary adenoma compression ``` hypothalamic tumor cystic lesion (craneofaringoma, Rathke, aracnoidoceles) ``` metastasis vascular lesions (necrosis) - no cells to produce hormenes
243
adenomas and hipoputuitarism
compress hypothalamus and pituitary and THH (tallo) decrease pit irrigation increase intrasellar pressure prolactinoma (PRL inhibits GnRH) corticotropoma (ACTH inhibits GnRH) so two hormones are down thru RAN down FSH, LH, testerone men, estradiol women
244
pituitary infart
apoplejia don't know if hemorrhage or infart acute both caus epituitary infarct (10-15% adenomas inernal hemorrhage??, autocorrection) local MC:cefalea, meningeal irritation, visual signs, altered conscieness, facial pain (due to increase in ICP - blood irritates calls cytokines and proinfalmmatory factors causing headache by VD) altrered sympathetic regulation obstructive hydrocefaly systemic: hypopituitarism empty silla turca syndrome
245
pathogenesis of apoplejjia
adenoma of pituitary grows fast mass compresses superior pit artery , less perfusion, necrosis can also cause its own vascular anomalies all 3 of these conditions cass perfusion insuff and causes isquemic necrosis --> death of pit cell death
246
pituitary infract, Sheehan syndrome
@ post partum blood loss in labor causes less blood flow up which is already big (pit) due to preg necrosis failed lactancy, failed reinico of menstruation, massive labor hemorrhage (PRL inhibits GnRH - after nipple stimulation) cells dead anyway no PRL or GnRH
247
infiltrations and infections for hipopituitarism
``` infiltrative: amyloidosis sarcoidosis histocitiosis X hemochromatosis (destroynormal tissue that's there) ``` ``` infection: micosis (coccido, crypto) Tb sifilis AIDS pituitary abcess ``` (hipofisisits linfocitica px ej?)
248
cranial injury hipopituitarism
trauma can be direct to brain ``` indirect.....causes of pituitary infarct cerebral edema (compresses) ``` hemorrhage or fracture of cranium (blood irritative ,and proinflammatory) cerebral hypoxia
249
iatrogenic causes of hipopituiraism
qx of pit gland due to hypothalamic lesion cranial RT (gammaknife) - waves destroy the mass/lesion but its not selective just like the surgery
250
hipofisitis --> hypopituitarism can be
primary or secondary
251
primary hipofisitis
linfocitic (1A) granulomatous xantomarous
252
secondary hipofisitis
``` local lesion (germinoma) systemic enf (saroidis) ```
253
isolated hypopituitarism ca n have 3 MC cx
isolated FSH LH down (without corticotropoma, hiperPRL) - kallman syndrome (anosmia --> hipogonadismo hippanotropica??) FSH alone hyperprolactimea TSH down alone (IRC, linfocitic hipofisitis, pseudohipoparatiroidism) ACTH down alone (hipofisitis linfocitic, Sheehan, cranial trauma, Tpit gene mutation)
254
tpit gene
transcription for??
255
empty silla turca cause
partial or toal deficiency in sella diaphragm and LCR infiltrates compresses pit gland
256
clinical empty silla turca
oftalmologica (hemaniopsia bitemporal, blurry, blind, papilledema), neurological (cefalea, increased pressure, convulsions, paraplejias), endrological (hipo) 50%
257
@ def GH
neonates: hipoglicemia, hiperbilirrubinemia, convulsions (confused with kernicterus) short stature - infantile, delayed denticion, facial mcizo hypoplasia, frente oprominente, small mouth, occipital prominence
258
@ def ACTH
tired, less quality sleep, less muscular dislipidemia
259
def gonadotropins
no cx sexuals ni 1 or secondary ``` criptoquidia micropene delayed puberty small testicles little pubic hair gynecomastia ``` adults: less libido less energy, less EPO, less testicle, heat waves, dyspareunia (SSAME AS MENOAPAUSE) amenorrea, dry vaginal, osteopenia
260
TSH def
``` HIPOTHYROIDISM MC weak dry skin palpebral edema adinamia, somnolencia hair falls cold skin thin nails striated bradipsiquia, bradilalia attention deficit memory loss depression, psycosis disfonia ```
261
def ACTH
``` depression weight loss postural hypotension (why) epigastric pain nausea vomit hipoglicemia (no contrareg_ hipnatremia anemia, linfocitosis ```
262
def GH
hipoglicemia induced with insulin GH < 10ng/ml in ALL samples give insulin (0.05-0.15 unidades/kg) to induce hipoglicemia take basal glicemia (84mg/dl ej) 0 measure glicemia, GH, cortisol 0, 15, 30, 45, 60, 90, 120 well done to dx if glicemia is < 40mg/dl or half of what px had a basal if (43 CANT USE) GH should be increasing >10 is no deficit - GH this test measures somatotrope and corticotrope RESRERVES to say px has GH deficit has to be 9 and down (1 at 10 = healthy) cortisol should go up and if not its a def in reserve of corticotrope cells (cut off is = 18, healthy below deficit) In all samples
263
contraregulating hormones
cortisol GH glucagon catecolamines @ hypoglycemia these hormones go up
264
masculine hypogonadism dx
infertile measure serum testosterone at 8 and 11am (nadir times) if < 300ng/dl = confirmation primary or secondary (gonadotripinas ) in primary will be one elevated?? secondary hipo hipo
265
hipogonisms in women
amenorrea measure LH, FSH, E2.... also prolactin E2 down , LH, FSH up - primary (karyotype, precoz menopause, autoimmune ooforitis) = menopause if > 50 E2 down, LH, FSH down secondary hypogonadism MRI hipsifis, evaluate hipo function, central? discart preg and hiperprolactinemia
266
insuff suprarenal dx
measure cortisol 8am (5-25) and 4pm (half) Cortisol in morning @ insuff should be < 3 if < 18 = falla adrenal if > 18mcg/dl = sano if 3-18 - short ACTH stimulation test - inject 250microg of ACTH or 0.25mg - cortisol up N, doesn't if sick (<18 = ADRENAL FAILURE)
267
hormone replacement tx GH
give GH in kids 0.035mg/kg/d SC
268
hormone replacement tx ACTH
give hydrocortisone - 20-30mg/d VO Prednisina 5-7.5mg/d VO Cortisone 25-37.5 mg/d VO
269
hormone replacement tx TSH
levoritoxine - 1.6-1.8mcg/kg/d VO
270
LH FSH
men - testerone esters 250mg C/3wk 2.5-7.5mg/d 5-10 gel/24hr women estrogen 1-2mg/d estrogen and progestogens 25-100ug/24hrs (combined birth control)
271
craneofaringioma
tumors atht originate in remnants of cells from Rathke sac and can cause hipopit in kids most common cause of hipopit in kids 2-3% of IC tumors seen in 2 peaks of life between 2-25yr or > 65yr 25% cause hypothalamic alterations 5% @ hypofisis both @ 70% 25-30% mixed 15% solid 55-60% cystic usually > 1cm = macroadenomas, mass effect --> hipopit highly invasice with hypothalamic extension
272
MC of craneofaringoam
neuro MC - headache, visual camp deficit, hydrocephaly, convulsions ``` hipopituiartism (tumba ADH) - 80% deficit MC delayed puberty DI ``` hyperprolactinemia - tallo effect <100ng/dl
273
dx of craneofaringeoma
MRI of hypofisis with gadolinio - fine, cortes, if small can catch it most are big (cant see calcifications which cystic lesions do become) CT craneo (can see calcifications) Xray (calcification, other lesion, silla turca issues) campimetric deficits altered III, IV, VI less visual acuity measure prolactin in plasma, FSH LH, estradiol, FSH LH testosterone RSH T4 free GH, IGF1 Cortisol ACTH hipoglicemia induced by insulin test (FOR LAS RESERVAS) -
274
tx craniofaringioma
qx | hormone replacement therapy
275
post qx complications for craneofaringioma
DI - 16-66% adrenal insuff 40% panhipopituitarism 23% hipotiroidism 28%